• FDA Logo

    From Designation to Differentiation: What QIDP Signals for TAXIS and the Future of Antimicrobial Innovation

    Antimicrobial resistance (AMR) is one of the most urgent and complex challenges in modern medicine. As existing antibiotics lose effectiveness, the need for novel therapies — and the infrastructure to support their development — has never been greater. The FDA’s Qualified Infectious Disease Product (QIDP) [...]

  • Hands, pills and bottle in closeup for person with antibiotics

    Innovation Alone Will Not Solve Antimicrobial Resistance

    Discussions around antimicrobial resistance (AMR) often focus on the urgent need for new antibiotics. And while therapeutic innovation remains essential, the long-term challenge of AMR extends beyond drug discovery alone. Developing effective treatments is only one part of a much larger healthcare infrastructure problem involving [...]

  • Crowd of people walking at crosswalk.

    Why Antimicrobial Resistance Is Emerging as One of Healthcare’s Most Important Investment Priorities

    Antimicrobial resistance (AMR) is often discussed as a future public health concern, but for healthcare systems, clinicians, and patients around the world, its impact is already measurable. Resistant infections are increasing the complexity and cost of care, limiting treatment options, and placing growing pressure on [...]

  • Hygienic shield protecting from virus, germs and bacteria.

    TAXIS Pharmaceuticals to Present Preclinical Data on Two Investigational Antibiotic Candidates at Upcoming American Society for Microbiology Conference

    Miami, FL – May 26, 2026 — TAXIS Pharmaceuticals, a clinical-stage company developing investigational anti-resistance therapies to address antimicrobial resistance (AMR), today announced that its scientific team will present preclinical data from two investigational antibiotic development programs addressing urgent AMR threats at the upcoming American [...]

  • Bacteria medical illustration

    TAXIS Pharmaceuticals Announces Publication of Preclinical Data on Investigational Efflux Pump Inhibitor TXA11114 in journal Antibiotics

    Miami, FL – May 12, 2026 — TAXIS Pharmaceuticals, a clinical-stage company developing investigational anti-resistance therapies to address antimicrobial resistance (AMR), today announced the publication of preclinical data in the peer-reviewed journal Antibiotics describing TXA11114, an investigational indole carboxamide efflux pump inhibitor (EPI) designed to [...]

  • Sad, unhappy man sitting and holding his head. Depression concept. Continuous line drawing. Illustration on gloomy gray background

    Antibiotic-Resistant STIs: Men’s Health Is Entering A New Era Of Therapeutic Risk

    This article was originally published on drugdiscoveryonline.com.  By Gregory G. Mario, MBA, president and CEO, TAXIS Pharmaceuticals For decades, sexually transmitted infections (STIs), such as gonorrhea and chlamydia, were viewed as straightforward to treat. A single injection or short oral course of antibiotics was typically sufficient. [...]

  • Bacterium Neisseria gonorrhoeae, Gonorrhea

    Confronting Antibiotic-Resistant STIs: Advancing Next-Generation DHFR Inhibitors for Dual-Pathogen Coverage

    For decades, infections like gonorrhea and chlamydia were treated as routine; a quick course of antibiotics and life went on. Now, that comfort is collapsing. Neisseria gonorrhoeae has steadily outmaneuvered drug after drug, such as macrolides, fluoroquinolones and more;1 and today we rely on a [...]

  • ContagionLive logo

    Antibiotic-Resistant Gonorrhea Emerges as a Growing Men’s Health Crisis During STI Awareness Month

    Author(s) Contagion Editorial Team TAXIS Pharmaceuticals Chief Scientific Officer Ajit Parhi, PhD, offers some insights on the disease burden, and an overview of his company’s pipeline around developing a therapy for this STI. April is sexually transmitted infection (STI) Awareness Month, and with it brings [...]

  • World Health Day

    World Health Day: How Antimicrobial Resistance Is Changing Medicine — A Layered Defense Approach

    World Health Day is a good moment to call attention to a silent emergency that’s putting the health of everyone on our planet at risk: Antimicrobial resistance (AMR) is quietly eroding the foundations of modern medicine. On a day when we talk about equity and [...]